ID   MOGT2_HUMAN             Reviewed;         334 AA.
AC   Q3SYC2; A8K7I3; Q3SYC1; Q6ZQZ2; Q86UH6; Q9H630;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 2.
DT   29-SEP-2021, entry version 120.
DE   RecName: Full=2-acylglycerol O-acyltransferase 2 {ECO:0000305};
DE            EC=2.3.1.22 {ECO:0000269|PubMed:12621063, ECO:0000269|PubMed:27184406};
DE   AltName: Full=Acyl-CoA:monoacylglycerol acyltransferase 2;
DE            Short=MGAT2;
DE            Short=hMGAT2;
DE   AltName: Full=Diacylglycerol O-acyltransferase candidate 5;
DE            Short=hDC5;
DE   AltName: Full=Diacylglycerol acyltransferase 2-like protein 5;
DE   AltName: Full=Monoacylglycerol O-acyltransferase 2;
GN   Name=MOGAT2 {ECO:0000312|HGNC:HGNC:23248}; Synonyms=DC5, DGAT2L5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING (ISOFORM 3),
RP   FUNCTION, SUBCELLULAR LOCATION, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE
RP   SPECIFICITY, AND CATALYTIC ACTIVITY.
RC   TISSUE=Intestine;
RX   PubMed=12621063; DOI=10.1074/jbc.m301633200;
RA   Yen C.-L.E., Farese R.V. Jr.;
RT   "MGAT2, a monoacylglycerol acyltransferase expressed in the small
RT   intestine.";
RL   J. Biol. Chem. 278:18532-18537(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Small intestine, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   VAL-9.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=12824082; DOI=10.1152/ajpendo.00179.2003;
RA   Lockwood J.F., Cao J., Burn P., Shi Y.;
RT   "Human intestinal monoacylglycerol acyltransferase: differential features
RT   in tissue expression and activity.";
RL   Am. J. Physiol. 285:E927-E937(2003).
RN   [6]
RP   CATALYTIC ACTIVITY.
RX   PubMed=16106050; DOI=10.1194/jlr.m500168-jlr200;
RA   Yen C.-L.E., Brown C.H. IV, Monetti M., Farese R.V. Jr.;
RT   "A human skin multifunctional O-acyltransferase that catalyzes the
RT   synthesis of acylglycerols, waxes, and retinyl esters.";
RL   J. Lipid Res. 46:2388-2397(2005).
RN   [7]
RP   CATALYTIC ACTIVITY.
RX   PubMed=18768481; DOI=10.1074/jbc.m800494200;
RA   Cheng D., Iqbal J., Devenny J., Chu C.H., Chen L., Dong J., Seethala R.,
RA   Keim W.J., Azzara A.V., Lawrence R.M., Pelleymounter M.A., Hussain M.M.;
RT   "Acylation of acylglycerols by acyl coenzyme A:diacylglycerol
RT   acyltransferase 1 (DGAT1). Functional importance of DGAT1 in the intestinal
RT   fat absorption.";
RL   J. Biol. Chem. 283:29802-29811(2008).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=27184406; DOI=10.1016/j.bbrc.2016.05.071;
RA   Brandt C., McFie P.J., Stone S.J.;
RT   "Biochemical characterization of human acyl coenzyme A: 2-monoacylglycerol
RT   acyltransferase-3 (MGAT3).";
RL   Biochem. Biophys. Res. Commun. 475:264-270(2016).
RN   [9]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=28420705; DOI=10.1194/jlr.m073445;
RA   Ma Z., Onorato J.M., Chen L., Nelson D.W., Yen C.E., Cheng D.;
RT   "Synthesis of neutral ether lipid monoalkyl-diacylglycerol by lipid
RT   acyltransferases.";
RL   J. Lipid Res. 58:1091-1099(2017).
CC   -!- FUNCTION: Catalyzes the formation of diacylglycerol from 2-
CC       monoacylglycerol and fatty acyl-CoA. Has a preference toward
CC       monoacylglycerols containing unsaturated fatty acids in an order of
CC       C18:3 > C18:2 > C18:1 > C18:0. Plays a central role in absorption of
CC       dietary fat in the small intestine by catalyzing the resynthesis of
CC       triacylglycerol in enterocytes. May play a role in diet-induced
CC       obesity. Also able to use 1-monoalkylglycerol (1-MAkG) as an acyl
CC       acceptor for the synthesis of monoalkyl-monoacylglycerol (MAMAG)
CC       (PubMed:28420705). {ECO:0000269|PubMed:12621063,
CC       ECO:0000269|PubMed:27184406, ECO:0000269|PubMed:28420705}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2-acylglycerol + an acyl-CoA = a 1,2-diacyl-sn-glycerol +
CC         CoA; Xref=Rhea:RHEA:32947, ChEBI:CHEBI:17389, ChEBI:CHEBI:17815,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:58342; EC=2.3.1.22;
CC         Evidence={ECO:0000269|PubMed:12621063, ECO:0000269|PubMed:27184406};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32948;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 2-(9Z-octadecenoyl)-glycerol = 1,2-di-
CC         (9Z-octadecenoyl)-sn-glycerol + CoA; Xref=Rhea:RHEA:37911,
CC         ChEBI:CHEBI:52333, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:73990; Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37912;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z-octadecenoyl)-glycerol = 1,2-di-
CC         (9Z-octadecenoyl)-glycerol + CoA; Xref=Rhea:RHEA:37915,
CC         ChEBI:CHEBI:52323, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:75342; Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37916;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-(9Z-octadecenoyl)-glycerol + butanoyl-CoA = 1-butyryl-2-
CC         (9Z)-octadecenoyl-sn-glycerol + CoA; Xref=Rhea:RHEA:38051,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57371, ChEBI:CHEBI:73990,
CC         ChEBI:CHEBI:75443; Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38052;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-(9Z-octadecenoyl)-glycerol + octanoyl-CoA = 1-octanoyl-2-
CC         (9Z)-octadecenoyl-sn-glycerol + CoA; Xref=Rhea:RHEA:38059,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57386, ChEBI:CHEBI:73990,
CC         ChEBI:CHEBI:75462; Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38060;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-(9Z-octadecenoyl)-glycerol + dodecanoyl-CoA = 1-dodecanoyl-
CC         2-(9Z)-octadecenoyl-sn-glycerol + CoA; Xref=Rhea:RHEA:38063,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57375, ChEBI:CHEBI:73990,
CC         ChEBI:CHEBI:75463; Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38064;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-(9Z-octadecenoyl)-glycerol + tetradecanoyl-CoA = 1-
CC         tetradecanoyl-2-(9Z)-octadecenoyl-sn-glycerol + CoA;
CC         Xref=Rhea:RHEA:38067, ChEBI:CHEBI:57287, ChEBI:CHEBI:57385,
CC         ChEBI:CHEBI:73990, ChEBI:CHEBI:75465;
CC         Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38068;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-(9Z-octadecenoyl)-glycerol + hexadecanoyl-CoA = 1-
CC         hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol + CoA;
CC         Xref=Rhea:RHEA:38071, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:73990, ChEBI:CHEBI:75466;
CC         Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38072;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-(9Z-octadecenoyl)-glycerol + octadecanoyl-CoA = 1-
CC         octadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol + CoA;
CC         Xref=Rhea:RHEA:38075, ChEBI:CHEBI:57287, ChEBI:CHEBI:57394,
CC         ChEBI:CHEBI:73990, ChEBI:CHEBI:75468;
CC         Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38076;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-(9Z-octadecenoyl)-glycerol + eicosanoyl-CoA = 1-eicosanoyl-
CC         2-(9Z)-octadecenoyl-sn-glycerol + CoA; Xref=Rhea:RHEA:38079,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57380, ChEBI:CHEBI:73990,
CC         ChEBI:CHEBI:75470; Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38080;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + 2-(9Z-octadecenoyl)-glycerol =
CC         1-(9Z,12Z)-octadecadienoyl-2-(9Z)-octadecenoyl-sn-glycerol + CoA;
CC         Xref=Rhea:RHEA:38083, ChEBI:CHEBI:57287, ChEBI:CHEBI:57383,
CC         ChEBI:CHEBI:73990, ChEBI:CHEBI:75471;
CC         Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38084;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 2-(9Z-octadecenoyl)-
CC         glycerol = 1-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-2-(9Z)-octadecenoyl-sn-
CC         glycerol + CoA; Xref=Rhea:RHEA:38087, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57368, ChEBI:CHEBI:73990, ChEBI:CHEBI:75472;
CC         Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38088;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-dodecanoylglycerol = 1-dodecanoyl-2-
CC         (9Z-octadecenoyl)-glycerol + CoA; Xref=Rhea:RHEA:38115,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:75539,
CC         ChEBI:CHEBI:75579; Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38116;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-tetradecanoylglycerol = 1-
CC         tetradecanoyl-2-(9Z-octadecenoyl)-glycerol + CoA;
CC         Xref=Rhea:RHEA:38119, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:75562, ChEBI:CHEBI:75582;
CC         Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38120;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-hexadecanoylglycerol = 1-
CC         hexadecanoyl-2-(9Z-octadecenoyl)glycerol + CoA; Xref=Rhea:RHEA:38123,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:69081,
CC         ChEBI:CHEBI:75585; Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38124;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-octadecanoylglycerol = 1-
CC         octadecanoyl-2-(9Z)-octadecenoylglycerol + CoA; Xref=Rhea:RHEA:38127,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:75555,
CC         ChEBI:CHEBI:75590; Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38128;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z,12Z-octadecadienoyl)-glycerol =
CC         1-(9Z,12Z-octadecadienoyl)-2-(9Z-octadecenoyl)-glycerol + CoA;
CC         Xref=Rhea:RHEA:38131, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:75568, ChEBI:CHEBI:75614;
CC         Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38132;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z,12Z,15Z-octadecatrienoyl)-
CC         glycerol = 1-(9Z,12Z,15Z-octadecatrienoyl)-2-(9Z-octadecenoyl)-
CC         glycerol + CoA; Xref=Rhea:RHEA:38135, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:75609, ChEBI:CHEBI:75610;
CC         Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38136;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-
CC         glycerol = 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-2-(9Z-octadecenoyl)-
CC         glycerol + CoA; Xref=Rhea:RHEA:38139, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:75611, ChEBI:CHEBI:75612;
CC         Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38140;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecane-1,2-diol + hexadecanoyl-CoA = 2-hydroxyhexadecyl
CC         hexadecanoate + CoA; Xref=Rhea:RHEA:38171, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57379, ChEBI:CHEBI:75586, ChEBI:CHEBI:75587;
CC         Evidence={ECO:0000269|PubMed:16106050};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38172;
CC         Evidence={ECO:0000305|PubMed:16106050};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-decanoylglycerol = 1-decanoyl-2-(9Z-
CC         octadecenoyl)-glycerol + CoA; Xref=Rhea:RHEA:38019,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:75547,
CC         ChEBI:CHEBI:85787; Evidence={ECO:0000269|PubMed:12621063};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38020;
CC         Evidence={ECO:0000305|PubMed:12621063};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-O-(9Z-octadecenyl)-glycerol = 1-O-
CC         (9Z-octadecenyl)-mono-(9Z-octadecenoyl)-glycerol + CoA;
CC         Xref=Rhea:RHEA:55340, ChEBI:CHEBI:34116, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:138734;
CC         Evidence={ECO:0000269|PubMed:28420705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:55341;
CC         Evidence={ECO:0000305|PubMed:28420705};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1,2-di-(9Z-octadecenoyl)-sn-glycerol =
CC         1,2,3-tri-(9Z-octadecenoyl)-glycerol + CoA; Xref=Rhea:RHEA:38219,
CC         ChEBI:CHEBI:52333, ChEBI:CHEBI:53753, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387; Evidence={ECO:0000269|PubMed:18768481};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38220;
CC         Evidence={ECO:0000305|PubMed:18768481};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-O-(9Z-octadecenyl)-mono-(9Z-
CC         octadecenoyl)-glycerol = 1-O-(9Z-octadecenyl)-2,3-di-(9Z-
CC         octadecenoyl)glycerol + CoA; Xref=Rhea:RHEA:55344, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57387, ChEBI:CHEBI:138734, ChEBI:CHEBI:138735;
CC         Evidence={ECO:0000269|PubMed:28420705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:55345;
CC         Evidence={ECO:0000305|PubMed:28420705};
CC   -!- ACTIVITY REGULATION: Inhibited by oleic acid and sphingosine, while it
CC       is stimulated by phosphatidylcholine, phosphatidylserine and
CC       phosphatidic acid. {ECO:0000250|UniProtKB:Q80W94}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=45 uM for sn-1-monooleoylglycerol {ECO:0000269|PubMed:12621063};
CC   -!- PATHWAY: Glycerolipid metabolism; triacylglycerol biosynthesis.
CC       {ECO:0000269|PubMed:27184406}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12621063, ECO:0000269|PubMed:27184406}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:12621063}. Cytoplasm, perinuclear
CC       region {ECO:0000269|PubMed:27184406}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q3SYC2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q3SYC2-2; Sequence=VSP_020358;
CC       Name=3; Synonyms=MGAT2V, Trunc;
CC         IsoId=Q3SYC2-3; Sequence=VSP_020359, VSP_020360;
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver, small intestine, colon,
CC       stomach and kidney. {ECO:0000269|PubMed:12621063,
CC       ECO:0000269|PubMed:12824082}.
CC   -!- SIMILARITY: Belongs to the diacylglycerol acyltransferase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY157608; AAO23672.1; -; mRNA.
DR   EMBL; AK026297; BAB15436.1; -; mRNA.
DR   EMBL; AK128620; BAC87534.1; -; mRNA.
DR   EMBL; AK291998; BAF84687.1; -; mRNA.
DR   EMBL; CH471076; EAW74983.1; -; Genomic_DNA.
DR   EMBL; BC103876; AAI03877.1; -; mRNA.
DR   EMBL; BC103877; AAI03878.1; -; mRNA.
DR   EMBL; BC103878; AAI03879.1; -; mRNA.
DR   CCDS; CCDS8240.1; -. [Q3SYC2-1]
DR   RefSeq; NP_079374.2; NM_025098.3. [Q3SYC2-1]
DR   BioGRID; 123154; 2.
DR   IntAct; Q3SYC2; 1.
DR   STRING; 9606.ENSP00000198801; -.
DR   BindingDB; Q3SYC2; -.
DR   ChEMBL; CHEMBL2439944; -.
DR   SwissLipids; SLP:000000299; -.
DR   iPTMnet; Q3SYC2; -.
DR   PhosphoSitePlus; Q3SYC2; -.
DR   BioMuta; MOGAT2; -.
DR   DMDM; 114150036; -.
DR   jPOST; Q3SYC2; -.
DR   MassIVE; Q3SYC2; -.
DR   PaxDb; Q3SYC2; -.
DR   PeptideAtlas; Q3SYC2; -.
DR   PRIDE; Q3SYC2; -.
DR   ProteomicsDB; 61855; -. [Q3SYC2-1]
DR   ProteomicsDB; 61856; -. [Q3SYC2-2]
DR   ProteomicsDB; 61857; -. [Q3SYC2-3]
DR   Antibodypedia; 31177; 151 antibodies.
DR   DNASU; 80168; -.
DR   Ensembl; ENST00000198801; ENSP00000198801; ENSG00000166391. [Q3SYC2-1]
DR   Ensembl; ENST00000525093; ENSP00000436537; ENSG00000166391. [Q3SYC2-3]
DR   Ensembl; ENST00000526712; ENSP00000436283; ENSG00000166391. [Q3SYC2-2]
DR   GeneID; 80168; -.
DR   KEGG; hsa:80168; -.
DR   UCSC; uc010rru.3; human. [Q3SYC2-1]
DR   CTD; 80168; -.
DR   DisGeNET; 80168; -.
DR   GeneCards; MOGAT2; -.
DR   HGNC; HGNC:23248; MOGAT2.
DR   HPA; ENSG00000166391; Group enriched (intestine, liver).
DR   MIM; 610270; gene.
DR   neXtProt; NX_Q3SYC2; -.
DR   OpenTargets; ENSG00000166391; -.
DR   PharmGKB; PA134936582; -.
DR   VEuPathDB; HostDB:ENSG00000166391; -.
DR   eggNOG; KOG0831; Eukaryota.
DR   GeneTree; ENSGT01030000234582; -.
DR   HOGENOM; CLU_023995_0_1_1; -.
DR   InParanoid; Q3SYC2; -.
DR   OMA; PFYRDYI; -.
DR   OrthoDB; 1347007at2759; -.
DR   PhylomeDB; Q3SYC2; -.
DR   TreeFam; TF314707; -.
DR   BRENDA; 2.3.1.22; 2681.
DR   PathwayCommons; Q3SYC2; -.
DR   Reactome; R-HSA-75109; Triglyceride biosynthesis.
DR   SABIO-RK; Q3SYC2; -.
DR   UniPathway; UPA00282; -.
DR   BioGRID-ORCS; 80168; 2 hits in 1007 CRISPR screens.
DR   ChiTaRS; MOGAT2; human.
DR   GeneWiki; MOGAT2; -.
DR   GenomeRNAi; 80168; -.
DR   Pharos; Q3SYC2; Tchem.
DR   PRO; PR:Q3SYC2; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q3SYC2; protein.
DR   Bgee; ENSG00000166391; Expressed in small intestine and 81 other tissues.
DR   Genevisible; Q3SYC2; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:1990578; C:perinuclear endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0003846; F:2-acylglycerol O-acyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0016407; F:acetyltransferase activity; IEA:Ensembl.
DR   GO; GO:0008374; F:O-acyltransferase activity; IBA:GO_Central.
DR   GO; GO:0006651; P:diacylglycerol biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006071; P:glycerol metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0050892; P:intestinal absorption; IEA:Ensembl.
DR   GO; GO:0006629; P:lipid metabolic process; IBA:GO_Central.
DR   GO; GO:0006640; P:monoacylglycerol biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome.
DR   InterPro; IPR007130; DAGAT.
DR   Pfam; PF03982; DAGAT; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Alternative splicing; Cytoplasm; Endoplasmic reticulum;
KW   Glycerol metabolism; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..334
FT                   /note="2-acylglycerol O-acyltransferase 2"
FT                   /id="PRO_0000249062"
FT   TRANSMEM        23..37
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        38..59
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        103..123
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..82
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020358"
FT   VAR_SEQ         218..284
FT                   /note="APLVPIFSFGENDLFDQIPNSSGSWLRYIQNRLQKIMGISLPLFHGRGVFQY
FT                   SFGLIPYRRPITTVV -> YQASGKSTLGSVGNWQGFYFGGKMAETNADSILVEIFSPF
FT                   TIKIIFWCLMPKYLEKFPQRRLSDLRN (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020359"
FT   VAR_SEQ         285..334
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020360"
FT   VARIANT         9
FT                   /note="M -> V (in dbSNP:rs554202)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_027390"
FT   VARIANT         196
FT                   /note="P -> H (in dbSNP:rs34582952)"
FT                   /id="VAR_048857"
FT   VARIANT         313
FT                   /note="C -> Y (in dbSNP:rs12281468)"
FT                   /id="VAR_027391"
FT   CONFLICT        142
FT                   /note="L -> P (in Ref. 2; BAB15436)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        267
FT                   /note="F -> L (in Ref. 2; BAC87534)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   334 AA;  38196 MW;  57C4A964BAFA76BD CRC64;
     MVEFAPLFMP WERRLQTLAV LQFVFSFLAL AEICTVGFIA LLFTRFWLLT VLYAAWWYLD
     RDKPRQGGRH IQAIRCWTIW KYMKDYFPIS LVKTAELDPS RNYIAGFHPH GVLAVGAFAN
     LCTESTGFSS IFPGIRPHLM MLTLWFRAPF FRDYIMSAGL VTSEKESAAH ILNRKGGGNL
     LGIIVGGAQE ALDARPGSFT LLLRNRKGFV RLALTHGAPL VPIFSFGEND LFDQIPNSSG
     SWLRYIQNRL QKIMGISLPL FHGRGVFQYS FGLIPYRRPI TTVVGKPIEV QKTLHPSEEE
     VNQLHQRYIK ELCNLFEAHK LKFNIPADQH LEFC
//